Edition:
United Kingdom

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

4.80USD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
150,684
52-wk High
$14.00
52-wk Low
$4.80

Chart for

About

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $644.09
Shares Outstanding(Mil.): 72.70
Dividend: --
Yield (%): --

Financials

  INSY.OQ Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -0.21 -- --
ROI: -5.71 9.00 14.96
ROE: -5.88 10.14 16.53

Opioid maker Insys paid kickbacks to physician assistant, jury hears

CONCORD, N.H. A former Insys Therapeutics Inc sales representative now married to the drugmaker's ex-CEO said on Wednesday she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

12 Dec 2018

UPDATE 2-Opioid maker Insys paid kickbacks to physician assistant, jury hears

CONCORD, N.H., Dec 12 A former Insys Therapeutics Inc sales representative now married to the drugmaker's ex-CEO said on Wednesday she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

12 Dec 2018

Physician assistant faces U.S. trial over Insys opioid kickbacks

Dec 12 A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc to prescribe a highly addictive fentanyl spray the drugmaker produced.

12 Dec 2018

Former Insys executive pleads guilty to opioid bribe scheme

BOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the company's powerful opioid medication and entered into a deal to cooperate with prosecutors.

29 Nov 2018

Former Insys executive pleads guilty to opioid bribe scheme

BOSTON A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the company's powerful opioid medication and entered into a deal to cooperate with prosecutors.

29 Nov 2018

UPDATE 3-Former Insys executive pleads guilty to opioid bribe scheme

BOSTON, Nov 28 A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the company's powerful opioid medication and entered into a deal to cooperate with prosecutors.

29 Nov 2018

Former executive at opioid maker Insys to plead guilty

BOSTON, Nov 28 A former executive at Insys Therapeutics Inc is expected to plead guilty on Wednesday to charges that he participated in a scheme to bribe doctors to prescribe the company's opioid drug.

28 Nov 2018

Maryland charges Insys with engaging in deceptive opioid scheme

Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.

06 Sep 2018

UPDATE 2-Maryland charges Insys with engaging in deceptive opioid scheme

Sept 6 Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.

06 Sep 2018

Maryland charges Insys engaged in deceptive opioid scheme

Sept 6 Maryland on Thursday charged Insys Therapeutics Inc with having engaged in deceptive practices that resulted in a powerful opioid medication the drugmaker produced that was meant for cancer patients being prescribed to other people.

06 Sep 2018

Earnings vs. Estimates